background
patient
chronic
obstruct
pulmonari
diseas
copd
experi
exacerb
condit
exacerb
event
defin
term
subject
descriptor
symptom
name
dyspnoea
cough
sputum
worsen
suffici
warrant
chang
medic
manag
need
reliabl
marker
reflect
patholog
mechan
underli
exacerb
sever
use
surrog
assess
treatment
effect
clinic
studi
littl
known
exist
studi
variabl
suggest
marker
chang
stabl
exacerb
phase
copd
attempt
find
best
surrog
exacerb
review
literatur
identifi
marker
chang
consist
manner
sever
exacerb
event
search
standard
databas
juli
use
major
keyword
term
studi
provid
demograph
spirometri
potenti
marker
clear
elig
criteria
includ
studi
central
tendenc
dispers
variabl
marker
report
collect
us
first
tabul
accord
sampl
size
atser
exacerb
sever
level
iii
criteria
due
possibl
similar
patient
level
ii
iii
data
also
redefin
categori
exacerb
name
outpati
level
inpati
level
ii
iii
combin
approach
perform
fix
effect
metaanalysi
report
variabl
includ
total
studi
report
juli
studi
investig
patient
copd
arteri
carbon
dioxid
tension
breath
rate
statist
differ
level
exacerb
sever
outand
inpati
set
measur
show
weak
relationship
either
level
set
insuffici
data
permit
metaanalysi
arteri
carbon
dioxid
breath
rate
vari
consist
manner
exacerb
sever
patient
set
mani
measur
show
weak
correl
explor
futur
longitudin
studi
assess
use
suggest
mathemat
model
techniqu
chronic
obstruct
pulmonari
diseas
copd
respiratori
diseas
character
airflow
limit
inflamm
lower
airway
diseas
worsen
patient
experi
exacerb
princip
symptom
dyspnoea
cough
sputum
exacerb
frequent
result
visit
gener
practition
offic
local
hospit
treatment
exacerb
occur
copd
patient
median
three
time
year
half
unreport
heterogen
copd
exacerb
make
difficult
defin
classifi
manag
due
rang
symptom
vari
treatment
requir
season
occurr
ambigu
aetiolog
address
problem
attempt
made
develop
consensu
definit
copd
exacerb
recent
american
thorac
societi
at
european
respiratori
societi
er
adopt
follow
definit
event
natur
cours
diseas
characteris
chang
patient
baselin
dyspnea
cough
sputum
beyond
daytoday
variabl
suffici
warrant
chang
manag
sever
exacerb
also
difficult
classifi
despit
variou
scheme
propos
deal
issu
at
er
also
jointli
suggest
classif
base
upon
sever
type
medic
manag
use
ie
exacerb
level
home
treatment
level
ii
hospit
level
iii
specialis
care
aim
scheme
improv
exist
manag
exacerb
serv
aid
assess
treatment
efficaci
differ
oper
definit
copd
exacerb
propos
past
help
determin
rel
import
particular
relationship
copd
progress
howev
definit
reli
primarili
symptom
along
absenc
standard
classif
degre
symptom
sever
delay
develop
new
therapi
condit
current
therapi
exacerb
evalu
base
abil
reduc
symptom
improv
patient
forc
expiratori
volum
one
second
fev
sinc
latter
strongli
correl
copd
mortal
howev
fev
discrimin
well
stabl
exacerb
state
copd
particularli
later
stage
diseas
henc
develop
biolog
marker
biomark
sensit
specif
sever
copd
exacerb
would
provid
investig
new
insight
direct
research
time
clinic
variabl
inflammatori
mediat
shown
associ
copd
exacerb
relat
morbid
mortal
includ
age
fev
forc
vital
capac
peak
expir
flow
bodi
mass
index
albumin
sodium
ph
eosinophil
interleukin
fibrinogen
creactiv
protein
signific
clinic
event
number
exacerb
per
year
number
hospit
admiss
per
year
time
relaps
day
hospit
regard
use
measur
clinic
studi
design
assess
drug
efficaci
costeffect
well
standard
exist
hospit
support
program
copd
howev
known
measur
chang
increas
sever
copd
exacerb
therefor
survey
medic
literatur
identifi
commonli
accept
variabl
suggest
marker
copd
exacerb
chang
accord
atser
level
exacerb
sever
longterm
aim
work
assess
sensit
specif
potenti
marker
use
futur
copd
studi
well
determin
marker
studi
fulli
integr
develop
new
drug
copd
search
standard
databas
sinc
use
medic
search
head
relat
term
obtain
major
consensu
document
relat
copd
exacerb
major
keyword
exacerb
unstabl
acut
bronchiti
variant
term
copd
phase
search
retriev
total
citat
citat
read
titl
abstract
citat
exclud
citat
concern
exacerb
coronari
arteri
diseas
myocardi
infarct
cystic
fibrosi
asthma
pulmonari
emboli
commun
pneumonia
citat
case
studi
letter
review
metaanalys
anim
studi
also
exclud
initi
screen
identifi
citat
paper
possibl
interest
retriev
origin
articl
electron
hard
copi
form
critic
read
articl
result
step
arriv
total
studi
final
review
analys
select
studi
base
avail
demograph
spirometri
clear
studi
elig
criteria
potenti
marker
use
assess
exacerb
object
literatur
review
data
analys
determin
baselin
measur
commonli
use
copd
exacerb
studi
chang
extent
exacerb
diseas
sever
determin
whether
copd
exacerb
model
event
timetoev
futur
investig
initi
consid
variou
exacerb
definit
classif
scheme
particular
suggest
rodriguezroisin
well
describ
pauwel
colleagu
howev
determin
atser
oper
classif
exacerb
sever
sensibl
feasibl
system
systemat
assess
patient
baselin
characterist
biomark
inform
major
publish
studi
therefor
use
classif
scheme
relat
clinic
histori
physic
find
diagnost
procedur
manag
exacerb
perform
data
abstract
studi
retriev
report
demograph
spirometri
smoke
statu
clinic
cytolog
biochem
variabl
well
suggest
marker
sever
exacerb
baselin
condit
ie
immedi
prior
exacerb
event
time
intervent
interest
investig
tabl
whenev
variabl
measur
stabl
condit
also
abstract
inform
studi
note
type
definit
use
defin
exacerb
symptomor
eventbas
well
research
question
ask
experiment
design
use
sponsorship
presenc
absenc
data
individu
studi
patient
data
organ
accord
sampl
size
smoke
statu
avail
cytolog
biochem
data
also
classifi
accord
collect
method
includ
sputum
induct
bronchial
biopsi
bronchoalveolar
lavag
bal
exhal
breath
sampl
blood
sampl
also
awar
possibl
studi
group
sever
level
ii
iii
per
atser
criteria
includ
review
may
experienc
similar
qualiti
care
medic
manag
report
adequ
origin
public
attempt
correct
problem
combin
exacerb
data
level
ii
iii
inpati
categori
compar
level
regard
outpati
categori
collect
calcul
studi
mean
median
standard
error
standard
deviat
confid
interv
interquartil
rang
use
statist
algorithm
microsoft
excel
conduct
fix
effect
metaanalys
obtain
mean
point
estim
confid
interv
two
standard
deviat
exacerb
level
exacerb
sever
level
ii
ii
iii
iii
compar
use
twotail
ztest
alpha
level
p
adjust
multipl
test
accord
bonferroni
correct
procedur
event
specif
exacerb
sever
level
larg
number
studi
median
data
avail
data
consid
normal
distribut
median
treat
mean
sinc
mani
studi
publish
data
individu
patient
limit
address
nonnorm
data
use
log
transform
perform
fix
effect
metaanalysi
obtain
mean
point
estim
confid
interv
two
standard
deviat
inpati
outpati
categori
measur
compar
categori
use
twotail
ztest
pvalu
search
strategi
yield
suitabl
studi
met
select
criteria
studi
publish
juli
week
refer
studi
found
lacdr
divis
pharmacolog
websit
total
number
studi
subject
includ
review
group
fell
exacerb
sever
level
level
ii
level
iii
reanalys
data
accord
outor
inpati
set
outpati
inpati
metaanalys
typic
studi
demograph
show
signific
overlap
confid
interv
studi
data
distribut
three
exacerb
sever
level
except
age
studi
patient
level
ii
mean
age
year
confid
interv
ci
year
compar
year
ci
year
patient
level
iii
p
tabl
demograph
reanalyz
accord
patient
set
determin
bodi
mass
index
statist
differ
outpati
set
mean
point
estim
kgm
ci
kgm
inpati
set
mean
point
estim
kgm
ci
kgm
p
tabl
spirometri
measur
forc
expir
volum
second
fev
forc
vital
capac
fvc
percent
predict
decreas
exacerb
level
ii
p
remain
unchang
level
ii
iii
figur
respect
howev
level
ii
iii
combin
creat
inpati
categori
variabl
statist
signifirespiratori
research
http
cant
decreas
inpati
versu
outpati
p
figur
respect
also
observ
trend
fev
fvc
figur
spirometri
measur
studi
avail
level
iii
metaanalysi
found
smoke
pack
year
increas
exacerb
sever
level
ii
statist
differ
p
figur
compar
pack
year
patient
set
statist
higher
inpati
outpati
p
figur
term
hemodynam
measur
heart
rate
show
statist
signific
differ
higher
level
ii
level
p
differ
mani
studi
variabl
measur
around
time
exacerb
variabl
measur
stabl
condit
copd
patient
ie
measur
taken
week
month
prior
exacerb
also
obtain
level
ii
iii
figur
heart
rate
also
higher
inpati
outpati
p
figur
clinic
measur
dyspnoea
ie
breath
rate
figur
borg
dyspnoea
score
tend
increas
level
ii
decreas
level
ii
iii
howev
breath
rate
demonstr
clear
statist
differ
three
level
p
level
ii
iii
borg
dyspnoea
score
statist
differ
p
statist
comparison
level
level
possibl
due
lack
data
patient
set
compar
breath
rate
show
clear
statist
differ
statist
lower
inpati
outpati
p
figur
exacerb
level
ii
iii
statist
differ
respect
ph
p
bicarbon
p
ph
decreas
level
ii
iii
wherea
bicarbon
increas
howev
insuffici
level
data
variabl
allow
statist
comparison
level
also
insuffici
data
avail
compar
outpati
inpati
term
blood
ga
measur
studi
arteri
carbon
dioxid
tension
paco
show
statist
signific
increas
increas
exacerb
sever
p
figur
well
outversu
inpati
p
figur
case
oxygen
satur
gradual
decreas
increas
exacerb
sever
statist
signific
differ
level
ii
p
well
level
iii
p
figur
also
decreas
go
outpati
inpati
set
p
figur
six
minut
walk
distanc
challeng
test
seem
show
decreas
trend
increas
exacerb
sever
chang
reach
statist
signific
also
case
outand
inpati
compar
mani
variabl
relat
spirometri
respiratori
statu
exacerb
hospit
event
categori
also
chang
significantli
exacerb
sever
outand
inpati
see
addit
file
enough
data
bacteriolog
virolog
categori
permit
metaanalys
studi
sampl
half
contain
data
biochem
variabl
conduct
review
copd
exacerb
literatur
determin
commonlyaccept
baselin
variabl
suggest
marker
chang
consist
manner
sever
copd
exacerb
index
copd
sever
use
recent
publish
atser
oper
classif
exacerb
sever
medic
manag
publish
literatur
rare
provid
suffici
detail
characteris
sever
patient
exacerb
addit
also
analyz
data
accord
outand
inpati
set
account
possibl
overlap
medic
manag
level
ii
iii
report
origin
public
longterm
aim
work
improv
qualiti
applic
exacerb
manag
identif
sensit
specif
marker
use
assess
treatment
effect
review
identifi
potenti
marker
exacerb
sever
assess
spirometri
measur
fev
fvc
predict
well
fev
fvc
observ
statist
signific
differ
exacerb
sever
outand
inpati
figur
b
one
drawback
pauciti
inform
level
iii
studi
confirm
clinic
situat
exacerb
worsen
specialis
care
requir
spirometri
measur
less
like
baselin
condit
exacerb
thu
data
rare
mani
publish
studi
number
smokingrel
pack
year
increas
exacerb
sever
show
clear
differ
outand
inpati
set
figur
find
consist
idea
copd
patient
smoke
longer
higher
likelihood
copd
exacerb
sever
accord
mean
point
estim
obtain
inpati
mmhg
b
studi
copd
patient
packyear
smoke
experi
increas
sever
copd
exacerb
howev
conclus
regard
find
limit
data
two
studi
level
iii
although
heart
rate
vari
littl
exacerb
level
ii
iii
import
note
substanti
elev
patient
figur
clearest
differ
inand
outpati
possibl
associ
anxieti
dyspnea
experienc
exacerb
occur
increas
heart
rate
cours
increas
oxygen
requir
heart
increas
heart
rate
may
also
result
underli
cardiovascular
diseas
promin
sever
copd
patient
relationship
ph
bicarbon
exacerb
sever
consist
sign
respiratori
acidosi
evid
copd
patient
exacerb
howev
due
shortag
data
level
proper
statist
conclus
variabl
difficult
make
relat
breath
rate
significantli
increas
level
ii
decreas
level
ii
iii
figur
first
observ
may
reflect
compon
exacerb
episod
ie
anxieti
dyspnea
well
physiolog
need
breath
maintain
adequ
blood
ga
level
reduct
level
iii
possibl
reflect
result
special
care
patient
given
ventilatori
support
return
breath
rate
normal
borg
dyspnea
score
show
trend
breath
rate
although
insuffici
data
level
allow
comparison
outand
inpati
data
compar
variabl
breath
rate
demonstr
clear
statist
differ
figur
borg
dyspnoea
score
hand
enough
studi
outpati
categori
perform
statist
test
overal
observ
trend
consist
fact
manag
dyspnoea
one
main
factor
gener
high
hospit
cost
associ
copd
exacerb
keep
direct
measur
dyspnoea
arteri
carbon
dioxid
tension
show
clear
relationship
exacerb
sever
patient
manag
set
figur
consist
conclus
report
medic
literatur
arteri
oxygen
tension
contrast
chang
exacerb
sever
patient
set
possibl
lack
correl
reflect
immedi
administr
supplement
oxygen
given
hypoxaem
patient
hospit
set
howev
decreas
trend
oxygen
satur
increas
exacerb
sever
clear
differ
outand
inpati
set
figur
consist
present
think
blood
ga
chang
commonli
accept
measur
suggest
biomark
poorli
reflect
exacerb
sever
fact
suffici
data
undertak
metaanalysi
see
addit
file
find
recal
us
depart
health
human
servic
report
exacerb
treatment
outcom
randomis
control
trial
aim
studi
creat
new
guidelin
improv
manag
copd
exacerb
studi
also
conclud
current
literatur
limit
term
number
studi
amount
detail
avail
well
reliabl
accuraci
clinic
assess
use
discrimin
copd
exacerb
caus
worsen
respiratori
statu
thu
observ
agre
previou
observ
regard
assess
unstabl
copd
literatur
previous
discuss
studi
use
review
predomin
hospit
patient
level
ii
howev
copd
occur
outpati
set
level
implic
studi
sinc
latter
popul
poorli
repres
basic
categoris
accord
atser
oper
scheme
classifi
sever
copd
exacerb
well
outand
inpati
categori
knowledg
first
undertak
type
literatur
review
thu
face
lack
consist
definit
exacerb
use
variou
studi
tri
overcom
difficulti
select
rank
clinic
studi
improv
compar
subject
studi
also
awar
clinic
studi
analys
differ
respect
comorbid
identifi
caus
exacerb
report
patient
elderli
therefor
like
suffer
one
coexist
diseas
asthma
cardiovascular
diseas
comorbid
make
interpret
find
difficult
respect
true
caus
exacerb
aetiolog
could
determin
suscept
patient
level
could
identifi
new
treatment
develop
help
prevent
onset
relat
hospit
cost
final
compat
studi
copd
exacerb
analys
may
limit
substanti
variat
time
locat
studi
exacerb
like
summer
mani
studi
fail
report
time
year
time
period
studi
implement
thu
season
effect
combin
low
incid
exacerb
per
patient
could
repres
inher
bia
addit
differ
institut
probabl
differ
standard
respect
diagnosi
manag
copd
exacerb
studi
perform
variat
may
also
explain
observ
inconsist
find
howev
attempt
overcom
possibl
bia
exacerb
level
ii
iii
subsequ
reanalysi
data
basi
outpati
inpati
set
observ
addit
onlin
file
scarciti
inform
particularli
biomark
differ
exacerb
level
also
unclear
us
whether
variabl
chang
exacerb
sever
causallyrel
henc
longitudin
studi
andor
less
restrict
elig
criteria
would
need
address
question
one
difficulti
tackl
problem
enorm
amount
time
expens
involv
implement
studi
addit
current
method
data
analysi
clinic
studi
limit
impos
assess
reduct
frequenc
total
suppress
exacerb
episod
ie
rare
event
nonev
overcom
drawback
obtain
accur
evalu
treatment
effect
copd
exacerb
altern
analyt
method
base
exampl
predict
mathemat
model
hidden
markov
chain
bayesian
forecast
tri
model
characteris
predict
rare
event
without
undertak
fullscal
longterm
longitudin
studi
approach
predict
rare
event
use
previous
studi
migrain
epilepsi
variou
cardiovascular
diseas
size
treatment
effect
measur
term
reduct
frequenc
repetit
event
within
given
probabl
within
given
time
period
one
exampl
mathemat
model
develop
includ
use
markov
model
predict
copd
exacerb
rate
clinic
trial
inhal
anticholinerg
bronchodil
tiotropium
exampl
model
develop
basi
prior
knowledg
exacerb
rate
estim
metaanalys
randomis
control
trial
data
gave
probabl
copd
exacerb
differ
stage
copd
anoth
studi
proport
hazard
model
use
identifi
risk
factor
copd
patient
hospitalis
due
exacerb
current
atser
guidelin
exacerb
consid
implic
use
probabilist
model
mean
assess
sever
copd
exacerb
effect
treatment
model
approach
may
offer
new
insight
variabl
relat
copd
exacerb
investig
research
plan
perspect
studi
find
gener
hypothes
relat
consider
could
evalu
futur
clinic
trial
one
hypothesi
combin
variabl
observ
chang
studi
ie
fev
fvc
fev
fvc
arteri
carbon
dioxid
breath
rate
heart
rate
pack
year
oxygen
satur
could
repres
new
definit
sever
exacerb
event
definit
literatur
includ
recent
atser
definit
indic
assess
patho
physiolog
variabl
sign
exacerb
simpli
regard
exacerb
worsen
normal
daytoday
symptom
andor
adjust
medic
manag
definit
encompass
clear
set
object
measur
would
use
medic
practition
predominantli
reli
clinic
judgement
past
experi
diagnos
exacerb
sever
well
assess
treatment
effect
anoth
import
consider
futur
clinic
trial
assess
treatment
effect
base
predict
exacerb
frequenc
intens
word
collect
data
rate
onset
resolut
exacerb
longitudin
studi
could
use
determin
probabl
second
third
fourth
etc
exacerb
event
individu
patient
alter
probabl
experiment
treatment
could
sensit
reliabl
approach
assess
treatment
effect
clinic
trial
record
daili
chang
symptom
medic
manag
lastli
find
obtain
copd
patient
experienc
least
one
exacerb
studi
assess
period
studi
also
patient
experi
exacerb
indic
fraction
copd
patient
may
regard
suscept
exacerb
wherea
anoth
fraction
exacerbationfre
would
interest
determin
variabl
identifi
studi
chang
latter
patient
group
accord
fev
publish
studi
stratifi
copd
patient
basi
exacerb
frequenc
gener
done
categoris
patient
either
infrequ
frequent
exacerb
less
greater
mean
three
exacerb
per
year
respect
studi
unabl
make
distinct
copd
patient
sinc
mani
publish
studi
provid
individu
patient
data
exacerb
frequenc
current
investig
commerci
databas
clinic
trial
enabl
us
look
patient
infrequ
frequent
exacerb
result
work
could
help
us
better
select
patient
well
identifi
potenti
marker
futur
longitudin
studi
current
manag
treatment
copd
exacerb
primarili
depend
evalu
symptom
rather
sign
relat
exacerb
event
found
arteri
carbon
dioxid
tension
breath
rate
consist
vari
sever
copd
exacerb
inversu
outpati
commonlyaccept
measur
suggest
biomark
exacerb
fail
show
consist
trend
lack
suffici
data
permit
metaanalysi
recommend
design
longitudin
studi
look
frequenc
exacerb
well
use
advanc
model
techniqu
improv
select
potenti
marker
categor
sever
copd
exacerb
assess
treatment
effect
futur
studi
copd
chronic
obstruct
pulmonari
diseas
